Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1Genital Diseases, Female 1

Interventions

niraparib 2anlotinib 2Robotic Surgical Procedures 2Paclitaxel 2Carboplatin 2Bevacizumab 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2temsirolimus 1olaparib 1carboprost tromethamine 1Watchful Waiting 1Transurethral Resection of Prostate 1Trabectedin 1Preoperative Care 1Pregnancy Tests 1Postoperative Care 1Ocoxin 1Laparoscopy 1Intraoperative Care 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1GX-188 vaccine 1Filgrastim 1Diffusion 1Dexamethasone 1Colposcopy 1CP protocol 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Genital Diseases, Female × carboprost tromethamine × Clear all
NCT05518812 2024-09-19

Carboprost (Hemabate) for Fibroid Resection

Northwestern University

Phase EARLY_PHASE1 Completed
19 enrolled

Genital Diseases, Female, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡